SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy models.
Ontology highlight
ABSTRACT: Disrupted liver regeneration following hepatectomy represents an "undruggable" clinical challenge associated with poor patient outcomes. Yes-associated protein (YAP), a transcriptional coactivator that is repressed by the Hippo pathway, is instrumental in liver regeneration. We have previously described an alternative, Hippo-independent mechanism of YAP activation mediated by downregulation of protein tyrosine phosphatase nonreceptor type 11 (PTPN11, also known as SHP2) inhibition. Herein, we examined the effects of YAP activation with a selective SHP1/SHP2 inhibitor, NSC-87877, on liver regeneration in murine partial hepatectomy models. In our studies, NSC-87877 led to accelerated hepatocyte proliferation, improved liver regeneration, and decreased markers of injury following partial hepa
SUBMITTER: Watkins RD
PROVIDER: S-EPMC9462473 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA